Pagina 14 - I migliori oncologi di Oncologia - TOP-676medici

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

2017: Oticon Medical Scientific Center Copenhagen Denmark.
2016: ICLO Teaching Center New Endoscopic Approaches to Lateral Skull Base, Inner Ear and Cerebello-Pontine Angle, Verona Italy
2016: World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw,Poland
2015: Cochlear Science and Research Center Berlin Germany.
2014: Cochlear implant Center Medel Company Innsburck, Austria.
2014: Hannover Medical School. Clinic for Laryngology, Rhinology and Otology, Hannover, Germany
2014: Academy of Hearing Aid Acoustics (Akademie für Hörgerate-Akustik), Lübeck, Germany.
2013: International European Sialendoscopy Training Center, Geneva, Switzerland.
2012: University clinic of ORL, Head and Neck Surgery, klinikum der Universitat, Munchen, Germany.
2012: University clinic of ORL, Head and Neck Surgery, Bern, Switzerland.
2011: University clinic of ORL, Head and Neck Surgery, klinikum der Universitat, Munchen, Germany.
2007: The Ohio State University, Medical Faculty, Department of Otolaryngology, Division of Otology and Neurotology. Columbus, Ohio, USA.
2006: University of Würzburg, Department of Otolaryngology, Division of Otology and Neurotology. Würzburg, Germany.
1999-2003 İnönü Üniversitesi Tıp Fakültesi Kulak Burun Boğaz Anabilim Dalı
1993-1999 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi

Turkish Otorhinolaryngology and Head and Neck Surgery Association

Turkish Otorhinolaryngology and Head and Neck Surgery Foundation

Turkish Rhinology Society

Tigris-Euphrates Basin Otorhinolaryngology and Head and Neck Surgery Association

Gaziantep Otorhinolaryngology Association

Turkish Otorhinolaryngology and Head and Neck Surgery Qualification Board

Turkish Otology Association

Malatya Otorhinolaryngology Association

American Academy of Otolaryngology Head and Neck Surgery

Mediterranean Society of Otology and Audiology

International Vertigo Association

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Education and Expertise

• ANKARA UNIVERSITY FACULTY OF MEDICINE

Diseases

• Brain Tumors
• Gastrointestinal Cancers
• Genitourinary Cancers
• Lymphoma
• Malign Melanoma
• Breast Cancer
• Sarcomas

Experience

• Internal Medicine Specialist; Süleyman Demirel University Medical Faculty Hospital Internal Medicine Department
• Medical Oncology Specialist; Hacettepe University Faculty of Medicine Oncology Hospital, Department of Medical Oncology

Professional Memberships

• ESMO (European Society for Medical Oncology), full membership
• Turkish Medical Oncology Association, full membership

Il medico è specializzato in Medicina Interna, Medicina Respiratoria e Ematologia Clinica, con oltre 20 anni di esperienza nella pratica medica. Con competenza nella somministrazione di chemioterapia e radioterapia, il medico è dedicato a fornire cure di qualità con un'enfasi sul comfort e la soddisfazione del paziente. Forte sostenitore della medicina basata sull'evidenza, il medico è impegnato nell'educazione del paziente e nell'assicurare decisioni sanitarie informate.<\/p>

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Il medico è un esperto in oncologia, specializzato nel trattamento dei tumori al fegato, cistifellea, stomaco, pancreas, tratti intestinali e seno. Il medico ha una significativa esperienza lavorativa come oncologo presso il Fuda Hospital, nonché presso il Bumrungrad International Hospital e il Royal Siriraj Hospital in Thailandia. Inoltre, il medico è membro dell'Associazione Cinese Anti-Cancro, evidenziando un impegno per il progresso del trattamento e della ricerca sul cancro.<\/p>

Il dottore è un oncologo esperto con 43 anni di esperienza nel campo. Specializzandosi in oncologia, il dottore è attualmente affiliato con il Fuda Cancer Hospital, contribuendo significativamente ai progressi nel trattamento del cancro e nella cura dei pazienti.<\/p>

 Posts and Affiliations

Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany

Lead Breast Cancer Research Program, Kliniken Essen-Mitte

Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

 Additional Roles

ESMO Faculty – Breast Cancer

Member of AWO Gyn – Commission for plastic and reconstructive surgery

Speaker of the AGIMed – Commission for Integrative Medicine of the AGO

Member of the Organ Commission Mamma of the AGO

Scientific Director of the WSG study group

Global PI, Head of clinical investigations and trials 27

IDMC´s, Steering Boards national and international

Scientific committee of international and national symposia in breast cancer and surgical oncology

 Organization Memberships

Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,

European Academy of Senology, German Cancer Society, German Society of Gynecology and

Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,

 Publications

Peer reviewed Publications: 322

First/Senior Author: 38

h-Index/i10-Index 66/232

Congress Abstracts/Proceedings: 443

Books/Book Chapter: 59

Invited oral Presentations/Lectures: 1032

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.